Invesaro

Stocks Comparison

Cme vs StoneX: revenue, profit, margins and growth compared

Cme brought in $6.5B of revenue in fiscal 2025, StoneX $132.4B in fiscal 2025. Revenue changed by +6.4% at Cme and +32.5% at StoneX on the year before, so StoneX grew faster. Cme kept 62.5% of its revenue as net profit, StoneX 0.2%. Free cash flow was $4.2B at Cme and $4.3B at StoneX.

Side by side, latest fiscal year

CMESNEX
Fiscal year endedFY2025 (December 31, 2025)FY2025 (September 30, 2025)
Revenue$6.5B$132.4B
Revenue growth+6.4%+32.5%
Net income$4.1B$305.9M
Net margin62.5%0.2%
Free cash flow$4.2B$4.3B
Free cash flow margin64.3%3.3%
Earnings per share (diluted)$11.16$5.89
Cash$4.4B$1.6B
Debtn/an/a
Price to earnings23.711.3
Market value$95.1B$8.1B
Dividend yield1.89%n/a
Rank by revenue in sector#84 of 444 · Finance#4 of 444 · Finance

Over the years

Revenue
CME FY2018: $4.3BCME FY2019: $4.9BCME FY2020: $4.9BCME FY2021: $4.7BCME FY2022: $5BCME FY2023: $5.6BCME FY2024: $6.1BCME FY2025: $6.5BSNEX FY2018: $27.6BSNEX FY2019: $32.9BSNEX FY2020: $54.1BSNEX FY2021: $42.5BSNEX FY2022: $66BSNEX FY2023: $60.9BSNEX FY2024: $99.9BSNEX FY2025: $132.4BFY18FY19FY20FY21FY22FY23FY24FY25
CME $6.5BSNEX $132.4B
Net income
CME FY2018: $2BCME FY2019: $2.1BCME FY2020: $2.1BCME FY2021: $2.6BCME FY2022: $2.7BCME FY2023: $3.2BCME FY2024: $3.5BCME FY2025: $4.1BSNEX FY2018: $55.5MSNEX FY2019: $85.1MSNEX FY2020: $169.6MSNEX FY2021: $116.3MSNEX FY2022: $207.1MSNEX FY2023: $238.5MSNEX FY2024: $260.8MSNEX FY2025: $305.9MFY18FY19FY20FY21FY22FY23FY24FY25
CME $4.1BSNEX $305.9M
Net margin
CME FY2018: 45.5%CME FY2019: 43.5%CME FY2020: 43.1%CME FY2021: 56.2%CME FY2022: 53.6%CME FY2023: 57.8%CME FY2024: 57.5%CME FY2025: 62.5%SNEX FY2018: 0.2%SNEX FY2019: 0.3%SNEX FY2020: 0.3%SNEX FY2021: 0.3%SNEX FY2022: 0.3%SNEX FY2023: 0.4%SNEX FY2024: 0.3%SNEX FY2025: 0.2%FY18FY19FY20FY21FY22FY23FY24FY25
CME 62.5%SNEX 0.2%
Revenue growth
CME FY2019: +13.0%CME FY2020: +0.3%CME FY2021: -4.0%CME FY2022: +7.0%CME FY2023: +11.1%CME FY2024: +9.9%CME FY2025: +6.4%SNEX FY2019: +19.1%SNEX FY2020: +64.6%SNEX FY2021: -21.4%SNEX FY2022: +55.3%SNEX FY2023: -7.8%SNEX FY2024: +64.1%SNEX FY2025: +32.5%FY19FY20FY21FY22FY23FY24FY25
CME +6.4%SNEX +32.5%
Free cash flow
CME FY2018: $2.3BCME FY2019: $2.4BCME FY2020: $2.5BCME FY2021: $2.3BCME FY2022: $3BCME FY2023: $3.4BCME FY2024: $3.6BCME FY2025: $4.2BSNEX FY2018: -$486.1MSNEX FY2019: $183.7MSNEX FY2020: $1.9BSNEX FY2021: $2.1BSNEX FY2022: -$279MSNEX FY2023: -$70.6MSNEX FY2024: $441.7MSNEX FY2025: $4.3BFY18FY19FY20FY21FY22FY23FY24FY25
CME $4.2BSNEX $4.3B

Fiscal years as each company reports them; the two may end in different months.

Questions about Cme and StoneX

Which is bigger by revenue, Cme or StoneX?

StoneX is bigger by revenue: $132.4B in fiscal 2025, against $6.5B for Cme in fiscal 2025.

Which keeps more of its revenue as profit, Cme or StoneX?

Cme had a net margin of 62.5% in fiscal 2025; StoneX had 0.2% in fiscal 2025.

Which grew revenue faster, Cme or StoneX?

In their latest fiscal years revenue changed by +6.4% at Cme and +32.5% at StoneX.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies